The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180, 122-129
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, H. W.
Right arrow Articles by Kim, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, H. W.
Right arrow Articles by Kim, C. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells1

Hyung W. Lim*, Jeeho Lee*, Peter Hillsamer{dagger} and Chang H. Kim2,*

* Laboratory of Immunology and Hematopoiesis, Department of Comparative Pathobiology, Purdue Cancer Center, Bindley Bioscience Center, and Birck Nanotechnology Center, Purdue University, West Lafayette, IN 47907; and {dagger} Sagamore Surgical Center, Lafayette, IN 47909

It is a question of interest whether Th17 cells express trafficking receptors unique to this Th cell lineage and migrate specifically to certain tissue sites. We found several Th17 cell subsets at different developing stages in a human secondary lymphoid organ (tonsils) and adult, but not in neonatal, blood. These Th17 cell subsets include a novel in vivo-stimulated tonsil IL17+ T cell subset detected without any artificial stimulation in vitro. We investigated in depth the trafficking receptor phenotype of the Th17 cell subsets in tonsils and adult blood. The developing Th17 cells in tonsils highly expressed both Th1- (CCR2, CXCR3, CCR5, and CXCR6) and Th2-associated (CCR4) trafficking receptors. Moreover, Th17 cells share major non-lymphoid tissue trafficking receptors, such as CCR4, CCR5, CCR6, CXCR3, and CXCR6, with FOXP3+ T regulatory cells. In addition, many Th17 cells express homeostatic chemokine receptors (CD62L, CCR6, CCR7, CXCR4, and CXCR5) implicated in T cell migration to and within lymphoid tissues. Expression of CCR6 and CCR4 by some Th17 cells is not a feature unique to Th17 cells but shared with FOXP3+ T cells. Interestingly, the IL17+IFN-{gamma}+ Th17 cells have the features of both IL17IFN-{gamma}+ Th1 and IL17+IFN-{gamma} Th17 cells in expression of trafficking receptors. Taken together, our results revealed that Th17 cells are highly heterogeneous, in terms of trafficking receptors, and programmed to share major trafficking receptors with other T cell lineages. These findings have important implications in their distribution in the human body in relation to other regulatory T cell subsets.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by National Institutes of Health-National Institute of Allergy and Infectious Diseases Grant AI063064, American Heart Association, and Crohn’s and Colitis Foundation of America (to C.H.K.).

2 Address correspondence and reprint requests to Dr. Chang Kim, Department of Comparative Pathobiology, 725 Harrison Street, Purdue University, West Lafayette, IN 47907. E-mail address: chkim{at}purdue.edu

3 Abbreviations used in this paper: PB, peripheral blood; Treg, regulatory T cell; 2° LT, secondary lymphoid tissues; CB, cord blood.




This article has been cited by other articles:


Home page
GutHome page
S Brand
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
Gut, August 1, 2009; 58(8): 1152 - 1167.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z.-Z. Yang, A. J. Novak, S. C. Ziesmer, T. E. Witzig, and S. M. Ansell
Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma
Cancer Res., July 1, 2009; 69(13): 5522 - 5530.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Nistala and L. R. Wedderburn
Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis
Rheumatology, June 1, 2009; 48(6): 602 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Rafei, P. M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, E. Birman, S. Yuan, Y. K. Young, M.-N. Boivin, K. Forner, et al.
Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner
J. Immunol., May 15, 2009; 182(10): 5994 - 6002.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita
MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice
Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Zhang, J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese
IFN-{beta}1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation
J. Immunol., March 15, 2009; 182(6): 3928 - 3936.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Deng, W. Ma-Krupa, A. T. Gewirtz, B. R. Younge, J. J. Goronzy, and C. M. Weyand
Toll-Like Receptors 4 and 5 Induce Distinct Types of Vasculitis
Circ. Res., February 27, 2009; 104(4): 488 - 495.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Chizzolini, R. Chicheportiche, M. Alvarez, C. de Rham, P. Roux-Lombard, S. Ferrari-Lacraz, and J.-M. Dayer
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
Blood, November 1, 2008; 112(9): 3696 - 3703.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. de Beaucoudrey, A. Puel, O. Filipe-Santos, A. Cobat, P. Ghandil, M. Chrabieh, J. Feinberg, H. von Bernuth, A. Samarina, L. Janniere, et al.
Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells
J. Exp. Med., July 7, 2008; 205(7): 1543 - 1550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.